There remains a lack of controlled evidence investigating the relationship between GLP-1 agonist therapy and inflammatory skin conditions, and the molecular mechanisms remain uncertain
Oxidation resistance of the sulfur amino acids: methionine and cysteine
If your real goal is faster soft-tissue recovery, fewer injuries, and a more durable training year, BPC-157 fits into that conversation well, particularly when supervised by a clinical team
The statements presented in this article have not been evaluated by the Food and Drug Administration
Exendin-4 (Ex-4), another GLP-1RA that is homologous to commercially available exenatide, ameliorated IR in primary neurons through insulin receptor substrate-1 (IRS-1), AKT, and glycogen synthase kinase-3 (GSK-3) pathways
In contrast, treating obesity with GLP-1RA decreases cardiovascular risk and the possible mechanisms of cardioprotection achieved by this class of drugs are discussed